The American Society for Transplantation and Cellular Therapy is an international professional membership association of more than 3,900 physicians, investigators and other health care professionals from more than 50 countries. Our mission is dedicated to improving the application and success of hematopoietic cell transplantation and related cellular therapies. We strive to be the leading organization promoting research, education and clinical practice in the field.

• Bylaws
• 2023 Annual Report
• 2022 Annual Report
• 2021 Annual Report
• 2020 Annual Report 
• 2019 Annual Report

What We Do

ASTCT promotes:

• Education
• Scholarly publications, including the renowned journal Transplantation and Cellular Therapy
• Clinical standards
• Research
• Patient access to care
• Recruitment of professionals to the field
• Identification and support for the work of young investigators
• Adoption of government policies and regulations helpful to advancing quality patient care

We help our members:

• Advance their skills and expertise in the field
• Stay on top of the latest developments through our various publications
• Find jobs and identify training opportunities
• Find highly qualified job candidates for their centers or organizations
• Network with — and learn from — the ASTCT community at meetings and events
• Get actively engaged through committees, special interest groups and the Corporate Council

What We Value

ASTCT holds in highest regard:

• Comprehensive development and advancement of the field of hematopoietic cell transplantation (HCT) and cellular therapy
• Excellence in clinical care and treatment outcomes through standards for hematopoietic cell transplantation and cellular therapy
• Innovative research to advance the science and clinical applications of other cellular therapies
• Rapid dissemination of basic and clinical HCT research findings within the medical field and to the general public

ASTCT has a rich history that spans more than 30 years, and we look forward to serving our members in the years to come.

In the early 1970s, only a few medical centers around the world performed stem cell transplants. As success rates improved and the practice expanded in the 1980s and 1990s, the need for a scientific and professional society dedicated to blood and marrow transplantation led to the establishment of the American Society for Blood and Marrow Transplantation (ASBMT) in 1993.

Our association has been instrumental in numerous advancements in blood and marrow transplantation, as well as the development of stem cell transplantation regulations and standards. In 1996, with the International Society for Cellular Therapy, we co-founded the Foundation for the Accreditation of Cellular Therapy, an accreditation program for BMT centers.

In 2019, ASBMT announced it was changing its name to better align with the membership. The rebranded ASTCT — the American Society for Transplantation and Cellular Therapy — established a new look and feel, but the mission remains the same.

Driven by a clear purpose and governed by well-considered bylaws and effective leadership, ASTCT has grown from a few hundred members to more than 3,900. And today, numerous academic centers around the world have a transplant program.

ASTCT recognizes that a diverse and inclusive workforce is critical to research excellence, innovation, and elimination of health care disparities. ASTCT respects and values diversity, and the benefit of its integration throughout the association in order to enrich our perspective, increase member value and leadership development. We strive to create a diverse group of leaders and promote more diversity and health equity within our specialty of medicine.

View the Joint Statement from ASTCT, CIBMTR, FACT, ISCT, and EBMT and most recent ASTCT Town Hall: A Conversation on Race that was held June 11, 2020 for all ASTCT members.